FDA
-
-
-
-
-
-
-
BofA Securities Starts Alvotech SA (ALVO) at Buy
-
-
-
-
-
-
-
Alvotech and Teva reach settlement for Eylea biosimilar launch in Q4 2026
-
-
-
-
-
-
-
FDA issues complete response letter for Alvotech AVT05 biosimilar application
-
-
-
-
-
-
-
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
-
-
-
-
-
-
-
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
-
-
-
-
-
-
-
Alvotech (ALVO) and Teva (TEVA) Announce SELARSDI Injection Now Available in the U.S.
-
-
-
-
-
-
-
Alvotech Reports Financial Results for the First Nine Months of 2024
-
335,956 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


